LU90697I2 - Combinaison d'-thyniyl oestradiol et d'ac-tate de mor-thisterone (femhrt) - Google Patents

Combinaison d'-thyniyl oestradiol et d'ac-tate de mor-thisterone (femhrt)

Info

Publication number
LU90697I2
LU90697I2 LU90697C LU90697C LU90697I2 LU 90697 I2 LU90697 I2 LU 90697I2 LU 90697 C LU90697 C LU 90697C LU 90697 C LU90697 C LU 90697C LU 90697 I2 LU90697 I2 LU 90697I2
Authority
LU
Luxembourg
Prior art keywords
thyniyl
thisterone
femhrt
mor
estradiol
Prior art date
Application number
LU90697C
Other languages
English (en)
Original Assignee
Pre Jay Holdings Ltd
Woco Invest Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27060286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU90697(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pre Jay Holdings Ltd, Woco Invest Ltd filed Critical Pre Jay Holdings Ltd
Publication of LU90697I2 publication Critical patent/LU90697I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LU90697C 1983-08-05 2000-12-13 Combinaison d'-thyniyl oestradiol et d'ac-tate de mor-thisterone (femhrt) LU90697I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52083483A 1983-08-05 1983-08-05
US06/635,236 US4826831A (en) 1983-08-05 1984-07-27 Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Publications (1)

Publication Number Publication Date
LU90697I2 true LU90697I2 (fr) 2001-02-13

Family

ID=27060286

Family Applications (5)

Application Number Title Priority Date Filing Date
LU90107C LU90107I2 (fr) 1983-08-05 1997-07-21 Combinaison d'oestrogènes et d'acétate de médroxy progestérone chevalin
LU90343C LU90343I2 (fr) 1983-08-05 1999-01-27 Combinaison d'oestradiol (sous forme d'hémihydrate) ph. eur 1mg et d'acétate de norethistérone (sous forme d'hémihydrate) ph. eur 0,5 m (activelle)
LU90697C LU90697I2 (fr) 1983-08-05 2000-12-13 Combinaison d'-thyniyl oestradiol et d'ac-tate de mor-thisterone (femhrt)
LU90696C LU90696I2 (fr) 1983-08-05 2000-12-13 Combinaison d'oestradiol et d'ac-tate de m-droxy progesterone (indivina)
LU91096C LU91096I2 (fr) 1983-08-05 2004-07-30 Méthode de traitement hormonal de troubles de la périménopause, ménopause et postménopause et emballage à préparations multiples dans ce but.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
LU90107C LU90107I2 (fr) 1983-08-05 1997-07-21 Combinaison d'oestrogènes et d'acétate de médroxy progestérone chevalin
LU90343C LU90343I2 (fr) 1983-08-05 1999-01-27 Combinaison d'oestradiol (sous forme d'hémihydrate) ph. eur 1mg et d'acétate de norethistérone (sous forme d'hémihydrate) ph. eur 0,5 m (activelle)

Family Applications After (2)

Application Number Title Priority Date Filing Date
LU90696C LU90696I2 (fr) 1983-08-05 2000-12-13 Combinaison d'oestradiol et d'ac-tate de m-droxy progesterone (indivina)
LU91096C LU91096I2 (fr) 1983-08-05 2004-07-30 Méthode de traitement hormonal de troubles de la périménopause, ménopause et postménopause et emballage à préparations multiples dans ce but.

Country Status (12)

Country Link
US (2) US4826831A (fr)
EP (1) EP0136011B2 (fr)
AT (1) ATE147987T1 (fr)
CA (1) CA1240927A (fr)
DE (5) DE19775086I2 (fr)
DK (2) DK165390C (fr)
IL (1) IL72556A (fr)
LU (5) LU90107I2 (fr)
MX (1) MX9203720A (fr)
NL (5) NL970026I1 (fr)
NZ (1) NZ209066A (fr)
PH (1) PH24052A (fr)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4961931A (en) * 1982-07-29 1990-10-09 Alza Corporation Method for the management of hyperplasia
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
CH674618A5 (fr) * 1987-04-02 1990-06-29 Ciba Geigy Ag
ATE66149T1 (de) * 1987-07-06 1991-08-15 Akzo Nv Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
EP0322020A1 (fr) * 1987-12-22 1989-06-28 Akzo N.V. Unité de dosage pharmaceutique pour traiter les troubles climactériques et l'ostéoporose
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product
DE69022722T2 (de) * 1989-03-10 1996-05-02 Endorecherche Inc Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen.
US5043331A (en) * 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
IL107343A (en) * 1992-11-02 2003-10-31 Wyeth Corp PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
US6037339A (en) * 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
US5710144A (en) * 1993-02-08 1998-01-20 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
DE19510861A1 (de) * 1995-03-16 1996-09-19 Schering Ag Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
WO1997004752A1 (fr) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Compositions pharmaceutiques d'oestrogenes conjugues et leurs modes d'emploi
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
US5654011A (en) * 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US6040333A (en) * 1996-07-30 2000-03-21 Energetics, Inc. Dietary supplements
US5807586A (en) * 1996-07-30 1998-09-15 Energetics, Inc. Method of dietary supplementation
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
EP1098653A2 (fr) * 1998-07-17 2001-05-16 PHARMACIA & UPJOHN COMPANY Acetate de medroxy-progesterone administrable par voie sous-cutanee a des fins contraceptives
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
EP1052980A1 (fr) * 1998-10-09 2000-11-22 PHARMACIA & UPJOHN COMPANY Acetate de medroxyprogesterone administre par voie sous-cutanee en vue du traitement de la menopause et de l'endometriose
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
US7025979B2 (en) 2000-02-15 2006-04-11 Schering Ag Male contraceptive formulation comprising norethisterone
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
US20020151530A1 (en) 2000-12-22 2002-10-17 Leonard Thomas W. Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform
US20060142257A1 (en) * 2001-01-19 2006-06-29 Eberhard Nieschlag Male contraceptive formulation comprising norethisterone
EA200301022A1 (ru) * 2001-03-16 2004-02-26 Уайт Гормональная заместительная терапия
WO2002078682A2 (fr) * 2001-03-16 2002-10-10 Wyeth Therapie de remplacement des oestrogenes
US8658627B2 (en) 2001-04-25 2014-02-25 The Regents Of The University Of California Pregnancy hormone combination for treatment of autoimmune diseases
US20130203722A1 (en) 2006-09-26 2013-08-08 Rhonda R. Voskuhl Estriol therapy for autoimmune and neurodegenerative disease and disorders
FR2823976A1 (fr) * 2001-04-25 2002-10-31 Theramex Nouvelle composition hormonale et son utilisation
EP1390038A2 (fr) * 2001-05-16 2004-02-25 Endeavor Pharmaceuticals Traitement d'etats lies a un deficit en hormones par administration de progestatifs
WO2003006027A1 (fr) * 2001-07-13 2003-01-23 Schering Aktiengesellschaft Combinaison de drospirenone et d'un sulfamate d'oestrogene destinee a une hormonotherapie substitutive
WO2003018026A1 (fr) * 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Utilisation de composes oestrogeniques combines avec des composes progestogeniques dans une hormonotherapie substitutive
WO2003049744A1 (fr) 2001-12-05 2003-06-19 Barr Laboratories, Inc. Contraceptifs oraux pour eviter les grossesses et diminuer la symptomatologie premenstruelle
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
WO2003084547A1 (fr) * 2002-04-03 2003-10-16 Barr Laboratories, Inc. Therapie oestrogenique a diminution graduelle
TW200306851A (en) * 2002-04-29 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200404551A (en) * 2002-05-17 2004-04-01 Wyeth Corp Hormone replacement therapy
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
US8946198B2 (en) * 2002-08-28 2015-02-03 Robert Casper Estrogen replacement regimen
EP1462106A1 (fr) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Compositions pharmaceutiques et trousses comprenant 17-beta estradiol et progesteron pour le traitement des troubles gynecologiques
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
JP2006522833A (ja) * 2003-04-11 2006-10-05 バー・ラボラトリーズ，インコーポレイテッド エストロゲンおよびプロゲスチンの投与法
EP1624848A4 (fr) * 2003-05-02 2009-02-25 Duramed Pharmaceuticals Inc Methodes de traitement hormonal faisant appel a des schemas contraceptifs a cycle prolonge
WO2005007112A2 (fr) * 2003-07-16 2005-01-27 Duramed Pharmaceuticals, Inc. Procedes de traitement hormonal utilisant des posologies contraceptives avec administration continue d'oestrogenes
WO2005030175A1 (fr) 2003-09-29 2005-04-07 Novo Nordisk Femcare Ag Formulations hrt
AU2004275470B2 (en) * 2003-09-29 2010-12-02 Novo Nordisk Health Care Ag Improved stability of progestogen formulations
BRPI0511569A (pt) * 2004-05-26 2008-01-02 Wyeth Corp composições e métodos para o tratamento de distúrbio disfórico pré-menstrual
DE102004026669A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
DE102004026679A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
CA2601773A1 (fr) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions d'oestrogenes non conjugues et procedes destines a leur utilisation
EP1971325A2 (fr) * 2005-12-27 2008-09-24 Duramed Pharmaceuticals, Inc. Compositions d' strogènes conjugués, applicateurs, kits et procédés pour les préparer et les utiliser
PE20081895A1 (es) * 2007-03-26 2009-01-26 Theramex Regimen anticonceptivo oral
AU2011240102B2 (en) 2010-04-15 2015-07-23 Bayer Intellectual Property Gmbh Very low-dosed solid oral dosage forms for HRT
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CA2856520C (fr) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Preparations et therapies de substitution pour hormonotherapie naturelle combinee
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2015168002A1 (fr) 2014-04-28 2015-11-05 The Regents Of The University Of California Conditionnement pharmaceutique pour thérapie à l'estriol
EP3137087B1 (fr) 2014-04-28 2023-09-06 The Regents of the University of California Combinaison d'oestrogènes pour le traitement de la sclérose en plaques
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3188735A4 (fr) 2014-09-02 2018-01-24 The Regents of the University of California Thérapie oestrogénique pour traitement l'atrophie de la matière grise cérébrale et le handicap associé
CA2962921A1 (fr) 2014-09-29 2016-04-07 The Regents Of The University Of California Compositions et methodes pour ameliorer la fonction cognitive
EP3277285A4 (fr) 2015-03-30 2018-12-19 The Regents of the University of California Méthodes de surveillance de thérapie à base d' oestriol
CN116077455A (zh) 2015-06-18 2023-05-09 埃斯特拉有限责任公司 含雌四醇组分的口腔分散剂量单位
CU24523B1 (es) 2015-06-18 2021-06-08 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (fr) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Compositions d'hormones stéroïdes dans des huiles à chaîne moyenne
CA3020153A1 (fr) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Composition pharmaceutique d'hormone steroide
KR20220144885A (ko) 2016-08-05 2022-10-27 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3733407A (en) * 1971-08-25 1973-05-15 Syntex Corp Menopause treatment
US3836651A (en) * 1972-02-22 1974-09-17 Biolog Concepts Inc Novel oral contraceptive combination
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents
DE2645307A1 (de) * 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
GB1578340A (en) * 1977-11-15 1980-11-05 Normalair Garrett Ltd Mechanical hands eg for diving apparatus
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms

Also Published As

Publication number Publication date
IL72556A (en) 1989-05-15
DE10199010I1 (de) 2002-05-08
EP0136011B2 (fr) 2004-06-09
NL970037I1 (nl) 1998-02-02
LU90343I2 (fr) 1999-03-29
IL72556A0 (en) 1984-11-30
EP0136011A3 (fr) 1986-07-16
MX9203720A (es) 1992-07-31
EP0136011B1 (fr) 1997-01-22
DE3486442T2 (de) 1997-06-05
NL300022I1 (nl) 2001-01-02
DK200400365A (da) 2004-03-04
DK175317B1 (da) 2004-08-16
NL300033I1 (nl) 2001-03-01
DK165390B (da) 1992-11-23
DE10199001I1 (de) 2002-03-14
DE10075037I1 (de) 2001-03-01
DK377084D0 (da) 1984-08-03
DE3486442D1 (de) 1997-03-06
PH24052A (en) 1990-03-05
NZ209066A (en) 1988-01-08
DE3486442T3 (de) 2005-05-12
DE10075037I2 (de) 2010-01-28
LU90107I2 (fr) 1997-12-17
NL300033I2 (nl) 2004-04-01
NL970026I1 (nl) 1997-10-01
NL980038I1 (nl) 1999-02-01
USRE36247E (en) 1999-07-06
NL980038I2 (nl) 2005-06-01
ATE147987T1 (de) 1997-02-15
DE10199001I2 (de) 2010-07-08
LU91096I2 (fr) 2004-11-30
DK165390C (da) 2004-04-26
CA1240927A (fr) 1988-08-23
LU90696I2 (fr) 2001-02-13
DK377084A (da) 1985-02-06
NL300022I2 (nl) 2004-04-01
US4826831A (en) 1989-05-02
NL970037I2 (nl) 2004-04-01
DE10199010I2 (de) 2010-01-28
EP0136011A2 (fr) 1985-04-03
DE19775086I2 (de) 2001-08-23

Similar Documents

Publication Publication Date Title
LU90697I2 (fr) Combinaison d'-thyniyl oestradiol et d'ac-tate de mor-thisterone (femhrt)
GR3003031T3 (en) Granule remaining in stomach
JPS5233994A (en) Preparation of modified polyolefin
JPS5441671A (en) Semiconductor device
JPS52125181A (en) Quinazolinone derivatives and preparation thereof
JPS53114886A (en) Skin packaging film
JPS5328164A (en) Maleimide derivatives
JPS5318551A (en) 4-homoprotoadamantane and its preparation
JPS5217797A (en) Indication device of expected arrivals
Farr NEWLY-COMPOSED EUCHARISTIC ENTRANCE ANTIPHONS, WITH COMMENTARY (INTROIT, MUSIC, LITURGY, HISTORY)
JPS52118453A (en) Indene derivatives
JPS5230176A (en) Manufacturing system of npn-transistor
GR1001395B (el) Συν?έσεις και μέ?οδοι προς πραγματοποίηση αντισύλληψης.
JPS52147873A (en) Automatic o-rings lining-up device
JPS51121628A (en) A carburetor
JPS51150091A (en) Cable wiring facilities
JPS5353668A (en) Novel isoquinoline alkaloids
JPS51143097A (en) Preparation of polyhydantoin
JPS51127959A (en) Fixing support method for pipe etc
JPS53118324A (en) Synchronization device